Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/23/2024
CCP Pledges "Health-First Strategy" for Medical and Healthcare Reform
7/22/2024
Wantai, GSK Terminate HPV Vaccine Development Deal
7/22/2024
Innovent's Lilly-Partnered Type 2 Diabetes Drug Succeeds in Phase III ...
7/22/2024
Gan & Lee Unveils Promising Mid-Stage Data for Homegrown Obesity Drug
7/19/2024
ExoNeuglia Secures Investment to Advance Clinical Trials for Neurodege...
7/19/2024
Rona Thera Raises $35M Series A+ Financing to Advance Innovative Metab...
7/19/2024
Exscientia Acquires Full Control of CDK7 Drug, Plans Breast Cancer Com...
7/19/2024
Eli Lilly Wins Label Expansion for Tirzepatide in China
7/19/2024
NHSA: DRG Grouping V2.0 to Be Released, Policy Tilt Towards Innovative...
7/19/2024
CDE Solicits Public Comments on the Technical Guidelines for In Vitro ...
7/19/2024
Beijing to Build International Pharma Innovation Park
7/19/2024
Chinese and Visiting Japanese Top Healthcare Officials Agree to Promot...
7/19/2024
Recent Executive Moves
7/19/2024
Experts Predict Novo Victory in Grueling Chinese Patent Case (MedWatcj...
7/18/2024
NMPA Solicits Public Comments on Drafts of the 'GMP for Pharmaceutical...
7/18/2024
NMPA Suspends Import, Sales and Use of Daiwoong's Cefodizime Sodium fo...
7/18/2024
India's Pharma Contract Manufacturing Sector Set to Double in Three Ye...
7/18/2024
Marinus's Ganaxolone Approved in China as First Treatment for Seizures...
7/18/2024
Merck Unveils GMP-Compliant Cell Culture Media Manufacturing Line in C...
7/18/2024
China Sets Up National Working Group to Standardize Healthcare Securit...
7/17/2024
Full-Life Tech, SK Biopharma Enter Licensing Deal for Novel Therapeuti...
7/17/2024
SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to E...
7/17/2024
Green Cross Sells Hong Kong Unit to China Resources Boya Bio
7/17/2024
CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...
7/17/2024
CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
7/17/2024
CDE Issues the Technical Guidelines for Clinical Trials of Drugs for G...
7/16/2024
NMPA Announces Package Insert Revision of Spleen Polypeptide Injection...
7/16/2024
U.S. Senators Introduce Bill to Reduce U.S. Dependence on China for Ph...
7/16/2024
Who Will Acquire Legend Bio for 13B to 15B USD? Could It Be J&J? (Drug...
7/16/2024
China's Health Supplements Market: Trends and Opportunities for Busine...
Page:
44
/
762
Total number of articles:
22840
:
[First]
[<<]
[42]
[43]
[44]
[45]
[46]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit